About this item:

413 Views | 396 Downloads

Author Notes:

Email: dreines@emory.edu

Author Contributions: Conceptualization: Travis J. Loya, Daniel Reines.

Data curation: Travis J. Loya.

Formal analysis: Travis J. Loya, Daniel Reines.

Funding acquisition: Daniel Reines.

Investigation: Travis J. Loya, Thomas W. O’Rourke, Daniel Reines.

Methodology: Travis J. Loya, Thomas W. O’Rourke, Daniel Reines.

Project administration: Daniel Reines.

Resources: Daniel Reines.

Supervision: Daniel Reines.

Validation: Travis J. Loya, Thomas W. O’Rourke, Daniel Reines.

Visualization: Travis J. Loya, Thomas W. O’Rourke.

Writing – original draft: Travis J. Loya, Thomas W. O’Rourke, Daniel Reines.

Writing – review & editing: Travis J. Loya, Thomas W. O’Rourke, Daniel Reines.

The authors thank Anna Kania and Juan Rodriguez for their contributions to this work during their rotation research.

We also thank Dr. Natalya Degtyareva for helpful discussions and tetrad analysis and Dr. Graeme Conn for a critical reading of the manuscript.

The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

The authors have declared that no competing interests exist.

Subject:

Research Funding:

This research project was supported in part by the Emory University School of Medicine Flow Cytometry Core.

Contributions of strains or antibodies from the labs of Drs. Pamela Silver, Maurice Swanson, and Michael Henry are acknowledged.

Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under awards R01GM120271.

Keywords:

  • Science & Technology
  • Multidisciplinary Sciences
  • Science & Technology - Other Topics
  • RNA-BINDING PROTEINS
  • CELL-FREE FORMATION
  • TRANSCRIPTION TERMINATION
  • SACCHAROMYCES-CEREVISIAE
  • POLYMERASE-II
  • YEAST NAB3
  • AGGREGATION
  • SELECTION
  • FEATURES
  • STRAINS
  • Prions
  • Yeast
  • RNA-binding proteins
  • Green Fluorescent Proteins
  • Plasmid construction
  • Protein sequencing
  • Transcriptional termination
  • Glutamine

The hnRNP-like Nab3 termination factor can employ heterologous prion-like domains in place of its own essential low complexity domain

Journal Title:

PLoS ONE

Volume:

Volume 12, Number 10

Publisher:

, Pages e0186187-e0186187

Type of Work:

Article | Final Publisher PDF

Abstract:

Many RNA-binding proteins possess domains with a biased amino acid content. A common property of these low complexity domains (LCDs) is that they assemble into an ordered amyloid form, juxtaposing RNA recognition motifs in a subcellular compartment in which RNA metabolism is focused. Yeast Nab3 is one such protein that contains RNA-binding domains and a low complexity, glutamine/proline-rich, prion-like domain that can self-assemble. Nab3 also contains a region of structural homology to human hnRNP-C that resembles a leucine zipper which can oligomerize. Here we show that the LCD and the human hnRNP-C homology domains of Nab3 were experimentally separable, as cells were viable with either segment, but not when both were missing. In exploiting the lethality of deleting these regions of Nab3, we were able to test if heterologous prion-like domains known to assemble into amyloid, could substitute for the native sequence. Those from the hnRNP-like protein Hrp1, the canonical prion Sup35, or the epsin-related protein Ent2, could rescue viability and enable the new Nab3 chimeric protein to support transcription termination. Other low complexity domains from RNA-binding, termination-related proteins or a yeast prion, could not. As well, an unbiased genetic selection revealed a new protein sequence that could rescue the loss of Nab3's essential domain via multimerization. This new sequence and Sup35's prion domain could also rescue the lethal loss of Hrp1's prion-like domain when substituted for it. This suggests there are different cross-functional classes of amyloid-forming LCDs and that appending merely any assembly-competent LCD to Nab3 does not restore function or rescue viability. The analysis has revealed the functional complexity of LCDs and provides a means by which the differing classes of LCD can be dissected and understood.

Copyright information:

© 2017 Loya et al

This is an Open Access work distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/).
Export to EndNote